Publications Office of the EU
Léčivé přípravky s účinnou látkou LIDSKÝ INHIBITOR ALFA1-PROTEINASY - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Léčivé přípravky s účinnou látkou LIDSKÝ INHIBITOR ALFA1-PROTEINASY

Overview
  • Published
    09/01/2025
  • Deadline
    10/02/2025
  • Canceled
    19/02/2025
  • Today
    10/08/2026
Status
Canceled
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice Brno
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ064 Jihomoravský kraj
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
The procedure is closed
Procedure details
Tender reference number
229/24
Description

Předmětem zadávacího řízení je uzavření rámcové kupní smlouvy na dodávky léčivých přípravků dle potřeb zadavatele.

Submission Method
Electronic via:
https://ezak.fnbrno.cz/
Tenders may be submitted
Electronic submission: required
https://ezak.fnbrno.cz/
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
CZ064 Jihomoravský kraj
CZ Česko
CPV code

33600000 - Pharmaceutical products

Award method
Nabídková cena
Estimated value
Not available
Final contracted value
The procedure is closed
Award of contract
The procedure is closed
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.